Avery W. Catlin
2009
In 2009, Avery W. Catlin earned a total compensation of $742.2K as Senior Vice President and Chief Financial Officer at Celldex Therapeutics, a 35% decrease compared to previous year.
Compensation breakdown
| Bonus | $65,000 |
|---|---|
| Option Awards | $382,970 |
| Salary | $288,607 |
| Other | $5,622 |
| Total | $742,199 |
Catlin received $383K in option awards, accounting for 52% of the total pay in 2009.
Catlin also received $65K in bonus, $288.6K in salary and $5.6K in other compensation.
Rankings
In 2009, Avery W. Catlin's compensation ranked 5,457th out of 9,885 executives tracked by ExecPay. In other words, Catlin earned more than 44.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,457 out of 9,885 | 45th |
Division Manufacturing | 1,956 out of 3,690 | 47th |
Major group Chemicals And Allied Products | 401 out of 866 | 54th |
Industry group Drugs | 254 out of 638 | 60th |
Industry In Vitro and In Vivo Diagnostic Substances | 16 out of 44 | 64th |
Source: SEC filing on April 24, 2012.
Catlin's colleagues
We found three more compensation records of executives who worked with Avery W. Catlin at Celldex Therapeutics in 2009.